# Precision genome surgery in autologous stem cell transplant

> **NIH NIH N02** · UNIVERSITY OF MARYLAND BALTIMORE · 2020 · $100,000

## Abstract

The NIH-funded Regenerative Medicine Innovation Catalyst will:
•	Provide in-depth and independent characterization of the source stem cell line and stem cell-derived products being developed,
•	Provide a platform for sharing and analysis of clinical trial (if applicable) and cell product characterization data, thereby potentially enabling correlation of stem cell-derived product attributes with clinical outcomes, and
•	Create a foundation for enhancing our understanding of clinical outcomes, refining production methods, and informing future RM product development.
Importantly, the RMIC will promote transparency and ultimately may contribute to reproducibility and standardization of clinical grade stem cell-derived products.

## Key facts

- **NIH application ID:** 10294658
- **Project number:** 75N92020P00309-0-0-1
- **Recipient organization:** UNIVERSITY OF MARYLAND BALTIMORE
- **Principal Investigator:** Stephen Tsang
- **Activity code:** N02 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $100,000
- **Award type:** —
- **Project period:** 2020-09-28 → 2021-09-27

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10294658

## Citation

> US National Institutes of Health, RePORTER application 10294658, Precision genome surgery in autologous stem cell transplant (75N92020P00309-0-0-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10294658. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*